Back

Prognostic value of galectin-3 according to carbohydrate antigen 125 in transcatheter aortic valve implantation

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Deep dive in TAVI Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Tobias Andreas Rheude

German Heart Center of Munich, Munich (Germany)

13 More presentations in this session

Presentation thumbnail
Psoas muscle area and volume and frailty scoring as predictors of outcomes after transcatheter aortic valve implantation
Professor P. Kleczynski (Krakow, PL)
Abstract Slides
Presentation thumbnail
Changes in valvulo-arterial impedance after transcatheter aortic valve implantation according to calcification burden of thoracic aorta
Doctor T. Gegenava (Tbilisi, GE)
Abstract Slides
Presentation thumbnail
Impact of serum hemoglobin level at discharge on long-term survival in patients undergoing transcatheter aortic valve implantation for severe aortic stenosis: an observational cohort study.
Doctor M. Okamoto (Bernau bei Berlin, DE)
Abstract
Presentation thumbnail
Durability and clinical outcomes at 5 to 9 years following transcatheter aortic valve implantation
Doctor A. Munoz Garcia (Malaga, ES)
Abstract Slides
Presentation thumbnail
Impact of new onset atrial fibrillation on outcome of patients undergoing transfemoral transcatheter aortic valve replacement
Mr R. Hoellriegel (Dresden, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Deep dive in TAVI

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources